Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation
Public ClinicalTrials.gov record NCT03663933. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase II Trial of Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation
Study identification
- NCT ID
- NCT03663933
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- National Cancer Institute (NCI)
- NIH
- Enrollment
- 71 participants
Conditions and interventions
Conditions
Interventions
- 2D ECHO Diagnostic Test
- Allogeneic HSC Procedure
- Bisulfan Drug
- Bone Marrow Aspirate & Biopsy Procedure
- Cyclophosphamide Drug
- DEXA Diagnostic Test
- EKG Diagnostic Test
- GVHD Prophylaxis Drug
- Immunosuppression Only Conditioning Procedure
- MMF Drug
- Mesna Drug
- PFTs Diagnostic Test
- Pentostatin Drug
- Prednisone Drug
- Reduced Intensity Conditioning Procedure
- Tacrolimus Drug
- e-ATG Drug
Diagnostic Test · Procedure · Drug
Eligibility (public fields only)
- Age range
- 4 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 3, 2018
- Primary completion
- Apr 2, 2025
- Completion
- Apr 2, 2030
- Last update posted
- Mar 16, 2026
2018 – 2030
United States locations
- U.S. sites
- 2
- U.S. states
- 2
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| National Institutes of Health Clinical Center | Bethesda | Maryland | 20892 | — |
| National Marrow Donor Program | Minneapolis | Minnesota | 55401 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03663933, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 16, 2026 · Synced May 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03663933 live on ClinicalTrials.gov.